Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Oric Pharmaceuticals Highlights 2025 Milestones at Guggenheim, Targets Phase 3 Prostate Trial in 1H25 - Stock Observer
Assetmark Inc. Buys 193,859 Shares of Pfizer Inc. $PFE
Daiwa Downgrades Pfizer (PFE) to Neutral Following Full-Year 2025 Earnings
Pfizer Inc. $PFE Shares Purchased by Public Sector Pension Investment Board - Daily Political
Metis Global Partners LLC Trims Stake in Pfizer Inc. $PFE - Daily Political
Pfizer Obesity And Hemophilia Advances Spark Fresh Interest In Valuation
Is Pfizer Inc. (PFE) One of the Best Medical Research Stocks to Buy According to Hedge Funds?
Pfizer (NYSE:PFE) Downgraded by Daiwa America to Hold - Markets Daily
Pfizer Hemophilia And Obesity Updates Add Context To Valuation Debate
Versor Investments LP Sells 37,800 Shares of Pfizer Inc. $PFE
Pfizer (NYSE:PFE) Lowered to "Hold" Rating by Daiwa America
Pfizer Inc. $PFE Shares Sold by Prospera Financial Services Inc
CENTRAL TRUST Co Has $10.19 Million Position in Pfizer Inc. $PFE - Markets Daily
Illinois Municipal Retirement Fund Cuts Stake in Pfizer Inc. $PFE
Pfizer Inc. $PFE Position Cut by CENTRAL TRUST Co - Stock Observer
GFS Advisors LLC Has $10.49 Million Position in Pfizer Inc. $PFE - Stock Observer
Kahn Brothers Reduces Stake in Pfizer Inc by 21.66%
Pfizer (NYSE:PFE) Lowered to Neutral Rating by Daiwa Securities Group - Markets Daily
ING Groep NV Sells 72,193 Shares of Pfizer Inc. $PFE - Markets Daily
Pharmaceutical Stocks To Watch Today - February 12th - Stock Observer
Pfizer (NYSE:PFE) Cut to Neutral at Daiwa Securities Group
Here Are Thursday's Top Wall Street Analyst Research Calls: BP Plc., Borg Warner, Generac, Kraft-Heinz, MercadoLibre, Pfizer, Shopify, Valvoline, and More
Pfizer Inc. $PFE Shares Purchased by LSV Asset Management
FTAs open up 70% of global GDP to India, largely at zero duty, says Piyush Goyal
Caprock Group LLC Makes New Investment in Pfizer Inc. $PFE
ING Groep NV Lowers Holdings in Pfizer Inc. $PFE - Stock Observer
Madison Asset Management LLC Has $6.17 Million Stock Position in Pfizer Inc. $PFE - Stock Observer
RFG Advisory LLC Has $1.27 Million Stock Position in Pfizer Inc. $PFE - Daily Political
Pfizer shares climb 13% in 3 days post Q3 results; is more steam left?
Disease progression patterns and association of prostate-specific antigen level with risk of progression in nonmetastatic castration-resistant prostate cancer
UK law firms consider action on behalf of women who developed brain tumours after using contraceptive
Pfizer Balances New Therapies And Pricing With Fresh Biotech Partnerships
Hedge Fund and Insider Trading News: Steven Cohen, Ray Dalio, Ken Griffin, Bill Ackman, Warren Buffett, Elliott Management, L1 Capital, Nextera Energy Inc (NEE), TransDigm Group Inc (TDG), and More
Pfizer Inc. $PFE Shares Sold by Oppenheimer Asset Management Inc.
Pfizer Inc. $PFE Shares Bought by Advisors Asset Management Inc.
FDA refuses to review Moderna's application for mRNA flu vaccine, company says | CNN
Pfizer Gets $29 Million of SAC Capital Insider Trade SEC Payout
Pfizer (NYSE:PFE) Sets New 1-Year High - Still a Buy?
Pfizer (NYSE:PFE) Shares Up 2.1% - Still a Buy?
Top Pharmaceutical Stocks To Consider - February 10th - Markets Daily
Promising Pharmaceutical Stocks To Watch Now - February 9th - Daily Political
Pfizer Inc. (PFE) Announces FDA's Grant of Priority Review for HYMPAVZI® (marstacimab) sBLA
EZH2 Targeted Therapy Market Research 2026: Ipsen Leads With Tazverik, Hengrui and Pfizer Advance Next-Generation EZH2 Programs - Opportunities, Approved Drug Prices, Sales, Clinical Trials Insights
Pfizer Standalone December 2025 Net Sales at Rs 645.03 crore, up 19.9% Y-o-Y
Volumes jump at Pfizer Ltd counter | Capital Market News - Business Standard
Pfizer shares gain 9% after Q3FY26 profit up 11%, revenue grows 20% - The Economic Times
Pfizer shares jump 11% on posting healthy Q3 show; PAT up 11% YoY, Rev 20% | Markets News - Business Standard
ACUTAAS CHEMICALS Share Price Today Up 6%
Pfizer standalone net profit rises 11.16% in the December 2025 quarter | Capital Market News - Business Standard
Pfizer Inc. (NYSE:PFE) Receives $28.06 Average Price Target from Analysts - Stock Observer
Entera Bio Names Former Pfizer Executive Geno J. Germano As Chairman
Candriam S.C.A. Has $51.81 Million Position in Pfizer Inc. $PFE
Oppenheimer & Co. Inc. Buys 61,829 Shares of Pfizer Inc. $PFE
Pfizer Inc. $PFE Shares Acquired by Allen Holding Inc. NY
OPTIMAS CAPITAL Ltd Makes New Investment in Pfizer Inc. $PFE
Why Pfizer's Valuation Depends on Drug Launches, Not Cost Cut | Investing.com
Pfizer Share Price Today 9 Feb 2026: Live NSE/BSE Rates, Technical Analysis and Expert Forecasts
Prognostic impact of myelodysplasia-related gene mutations in FLT3 -ITD-mutated acute myeloid leukemia
Dr. Scott Gottlieb says measles outbreak may "get worse, unfortunately, before it resolves" - CBS News
Transcript: Scott Gottlieb on "Face the Nation with Margaret Brennan," Feb. 8, 2026 - CBS News
Immunovant (NASDAQ:IMVT) Issues Earnings Results, Beats Expectations By $0.11 EPS - Markets Daily
Pfizer (NYSE:PFE) Stock Price Up 2.8% - Should You Buy? - Markets Daily
Pfizer Inc. $PFE Shares Acquired by Alps Advisors Inc.
Immunovant, Inc. (NASDAQ:IMVT) Q3 2026 Earnings Call Transcript
Roivant Sciences Ltd. (NASDAQ:ROIV) Q3 2025 Earnings Call Transcript
PFE: Obesity Pipeline And LOE Headwinds Will Shape Future Re Rating
Pfizer Inc. (NYSE:PFE) Receives Average Recommendation of "Hold" from Brokerages
What Pfizer (PFE)'s Monthly GLP-1 Obesity Drug Push Means For Shareholders
Murphy Pohlad Asset Management LLC Decreases Stock Holdings in Pfizer Inc. $PFE - Daily Political
Pfizer Inc. $PFE Shares Purchased by Canada Post Corp Registered Pension Plan - Daily Political
Pfizer (NYSE:PFE) Stock Price Up 2.8% - Time to Buy?
Healthy Returns: Pfizer execs talk Metsera obesity drug
Roivant Sciences Ltd (ROIV) Q3 2025 Earnings Call Highlights: Strategic Advances and Financial ...
Unusual Options Activity Alert: 3 Stocks Setting Up for Major Profit Potential
Pfizer (NYSE:PFE) Stock Price Up 2.8% - What's Next? - Stock Observer
TrumpRx is here. This is why it won't lower drug prices for most Americans. | Morningstar
Top Pharmaceutical Stocks To Follow Now - February 6th - Daily Political
GoodRx powers pricing for leading brand medications on TrumpRx
FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need
White House debuts drug-buying site TrumpRx, with roughly 40 medications
White House launches TrumpRx discounted drug site - CBS News
Program offers significant savings on over 30 brands spannin
TrumpRx is here. Here's why it will not lower drug prices for most Americans. | Morningstar
TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. | Morningstar
TrumpRx, the prescription drug website, set to launch - Yahoo News Canada
Pfizer Q4 Earnings Call Highlights - Daily Political
Pfizer (NYSE:PFE) Stock Price Down 1.1% - What's Next? - Daily Political
SBI Securities Co. Ltd. Purchases 89,822 Shares of Pfizer Inc. $PFE
Beacon Harbor Wealth Advisors Inc. Boosts Stock Holdings in Pfizer Inc. $PFE - Markets Daily
Pfizer's Obesity Bet PF-3944 Advances As Shares Screen Undervalued
BioPhorum announces formation of Strategic Advisory Board to accelerate industry collaboration
Pfizer (NYSE:PFE) Issues Quarterly Earnings Results - Stock Observer
Pfizer Obesity Trial Results Spark Questions On Valuation And Dividend Risk
Pfizer Inc. (PFE): A Bull Case Theory
